Analytics going viral - Tools to meet the needs of viral vector analysis

KTN is pleased to announce an afternoon event to discuss the current state of the art, challenges and potential solutions around analysis of adeno-associated virus and lentiviral vectors.

Join us if you would like to hear about the current state of the art for viral vector analytics, as well as its challenges. In addition, we will cover potential solutions.


Date: Wednessday, 7 July 2021

Time: 14:00-17:30

Click here to register


The event will include contributions from speakers representing companies, academia, RTOs and others. In addition, there will be an opportunity for solution providers to provide a short two-minute video to be shared with attendees in a video gallery. Two of the submissions will be selected by the organising committee for plenary display. The final session will be a panel discussion to revisit the issues raised in the preceding presentations.

Confirmed speakers and panelists:

  • Farzin Farzaneh, Chief Scientific Officer, ViroCell Biologics
  • Julia Leach, Senior Scientist – Analytical, CPI
  • Peng Wang, Scientist II, Lonza
  •  Yuan Zhao, Principal Scientist / Section Head, NIBSC
  • Mike Baker, Senior Director, FUJIFILM Diosynth Biotechnologies
  • Alan Dickson, Professor of Biotechnology, University of Manchester

After the plenary sessions there will be an opportunity to set up 1:1 video calls with other attendees.


Organising committee:

  • Karen Wilkinson, KTN
  • Marcel Kuiper, KTN
  • Joanne Flannelly, University of Manchester / BioProNET2
  • Alan Dickson, University of Manchester / BioProNET2
  • Rebecca Horlock, FUJIFILM Diosynth Biotechnologies
  • Daniel Petit, FUJIFILM Diosynth Biotechnologies
  • Robert Forbes, University of Central Lancashire / FUJIFILM Diosynth Biotechnologies
  • Julia Leach, CPI
  • Lee Dunham, Cell and Gene Therapy Catapult


Draft Agenda

14:00 – 14:10  Welcome and KTN update  Karen Wilkinson  KTN

Session 1: Challenges for viral vector analytics. Chair: Mike Baker (FUJIFILM Diosynth Biotechnologies)

14:10 – 14:25 “lentiviral vector analysis; state of the art and challenges”  Farzin Farzaneh  Chief Scientific Officer, ViroCell, Professor of Molecular Medicine, King’s College London

14:25 – 14:40  “AAV viral vector analysis; state of the art and challenges”  Peng Wang  Scientist II, Lonza

14:40 – 15:55  “Current and future regulatory expectations for AAV and lentiviral vector analytics”  Yuan Zhao  NIBSC

14:55 – 15:15  Q&A


Session 2: Exploration of novel tools and solutions. Chair: Julia Leach, CPI

15:15 – 15:20  Two selected videos from analytics solution providers (SME/academia)  TBC

15:20 – 15:35  “Future direction analytical capabilities”  TBC

15:35 – 15:45  Q&A

15:45 – 16:00  Break, novel solution videos


Session 3: Round table discussion led by Prof Alan Dickson (UoM)

with participation from Farzin Farzaneh (ViroCell/KCL), NIBSC (Yuan Chao), CPI (Julia Leach), Mike Baker (FDB), solution provider (TBC)

16:00 – 16:45

  • Key challenges
  • Learnings from other biopharmaceuticals
  • Novel technologies
  • Future regulatory expectations
  • Next steps

16:45 – 17:30  1:1 video networking, novel solution videos


Click here to register for this event

Share this article


24th August 2022

Advanced Therapies Europe 2022

August 31, 2022
Royal Lancaster London